publication . Article . Conference object . 2016

Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Mercer, Amanda; Gleasner, Cheryl; Erkkila, Tracy; Johnson, Shannon; Jaradat, Saied; Haddad, Hazem; Cui, Helen;
Open Access English
  • Published: 31 Dec 2016 Journal: Krankenhaus-Hygiene + Infektionsverhutung, volume 36, issue 1, pages 34-35 (issn: 0720-3373, eissn: 1876-4495, Copyright policy)
  • Publisher: Published by Elsevier B.V.
The Middle East respiratory syndrome coronavirus (MERS-CoV) as a causative agent of severe lower respiratory tract infection in humans, considered as a global threat, especially against to Persian Gulf countries. Since its discovery in 2012, MERS-CoV has spread 27 countries affecting about 1800 people and caused more than 600 deaths in worldwide. In comparison to SARS (severe acute respiratory syndrome), MERS-CoV appears to have a higher mortality rate (40% versus 10%) and is particularly more severe in patients with underlying medical conditions. Until now, the most MERS-CoV cases (more than 85 percent) have had a history of travel or residence in the Middle Ea...
Medical Subject Headings: virusesvirus diseases
free text keywords: Article, Middle East respiratory syndrome, MERS-CoV, Acute respiratory illness, SARS, Microbiology, QR1-502, WHO News Release, Virology, Medicine, business.industry, business, Middle East respiratory syndrome coronavirus, medicine.disease_cause, Respiratory system, Common cold, medicine.disease, Coronavirus
Any information missing or wrong?Report an Issue